Robert E Landry insider trades

Open-market stock purchases and sales by Robert E Landry, Director at Cytokinetics Inc, from SEC Form 4 filings since Sep 9, 2013.

Recent trades

DateStockTradeValue
Sep 15, 2026CYTK Cytokinetics IncSold$72.1K
Sep 11, 2026CYTK Cytokinetics IncSold$74.7K
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
Jan 12, 2026ZYME Zymeworks IncBought (not open market)—
Jan 12, 2026ZYME Zymeworks IncBought (not open market)—

Companies traded

  • CYTK Cytokinetics Inc: 2 sales, last Sep 15, 2026
  • ZYME Zymeworks Inc: other filings, last Jan 12, 2026
  • REGN Regeneron Pharmaceuticals, Inc: 260 sales, last Feb 2, 2024

Get free alerts when Robert E Landry files a new trade →